Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 6/20 | 0.72 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.64 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.64 |
| ▸ | HTR3A | P46098 | 1/20 | 0.64 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL927781 | 1.00 | CHRNA7 (0.72) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL928716 | 1.00 | CHRNA7 (0.72) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL927550 | 0.88 | CHRNB4 (0.64) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL928227 | 0.88 | CHRNA7 (0.56) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL929221 | 0.86 | CHRNA7 (0.54) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL929219 | 0.86 | CHRNA7 (0.54) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL928544 | 0.86 | CHRNA7 (0.54) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL928212 | 0.86 | CHRNA7 (0.54) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL5417932 | 0.86 | CHRNA7 (0.54) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 | |
| SCHEMBL927501 | 0.85 | CHRNA7 (0.53) | CHRNA7CHRNB4CHRNA3HTR3ACHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316836-A1 | Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors | Abbott Laboratories (US) | 2011-05-04 | — | — | EP | claimed |
| US-7399765-B2 | Substituted diazabicycloalkane derivatives | ABBOTT LABORATORIES (US) | 2008-07-15 | — | — | US | claimed |
| JP-2007521323-A | — | — | 2007-08-02 | — | — | JP | claimed |
| EP-1664045-A1 | SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS | Abbott Laboratories (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005028477-A1 | SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETY LCHOLINE RECEPTORS | ABBOTT LABORATORIES (US) | 2005-03-31 | — | — | WO | claimed |
| EP-2316836-A1 | Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors | Abbott Laboratories (US) | 2011-05-04 | — | — | EP | disclosed |
| EP-1664045-A1 | SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS | Abbott Laboratories (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005028477-A1 | SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETY LCHOLINE RECEPTORS | ABBOTT LABORATORIES (US) | 2005-03-31 | — | — | WO | disclosed |